Prot #5F9009: ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date8/18/20 → 8/18/24

Funding

  • ICON Clinical Research, LLC ((OE) Prot #5F9009 // (OE) Prot #5F9009)
  • Forty Seven, Inc. ((OE) Prot #5F9009 // (OE) Prot #5F9009)